The filing is a routine passive disclosure by a Texas-based investor. The simultaneous filing by Douglas K. Bratton (also Fort Worth) suggests a coordinated group filing may be in process — monitor for any subsequent SC 13D conversion or additional 13G amendments that could signal activist intent.
Price Chart
Executive Summary
Edward P. Bass and his affiliated entity Thru Line L.P. filed a new Schedule 13G disclosing beneficial ownership of approximately 7.5% of Aquestive Therapeutics' common stock. The filing is passive under Rule 13d-1(c), indicating no intent to influence control, and the stake is held through a combination of direct shares and Thru Line L.P.
Key Financial Metrics
Key Facts
- Edward P. Bass beneficially owns 9,385,561 shares (7.5%) of Aquestive Therapeutics common stock.
- Thru Line L.P. holds 7,876,267 shares (6.3%); Bass holds 1,509,294 shares individually.
- Filing is made under Rule 13d-1(c) — passive, no intent to change or influence control.
- This is a new initial Schedule 13G filing (not an amendment).
- A prior Schedule 13G/A was filed by Douglas K. Bratton on the same date, also from Fort Worth, Texas.
Financial Impact
Passive 7.5% stake disclosure — no financial impact from the filing itself.
Risk Factors
- No immediate risk — passive filing confirms passive intent.
- Potential future conversion to SC 13D if Bass or Bratton group becomes active.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0000897423-26-000125 |
| Document: 0000897423-26-000125-index.html | 0000897423-26-000125 |
| Document: 0000897423-26-000125.txt | 0000897423-26-000125 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 15, 2026 11d ago | 8-K | $4.06 $4.13 | ▲ +1.72% | ▲ +2.74% | $3.97 (−2.22%) |
Oct 15, 2026 11d ago | Press Release | $4.06 $4.13 | ▲ +1.72% | ▲ +2.74% | $3.97 (−2.22%) |
Oct 14, 2026 12d ago | 8-K | $4.61 $4.08 | ▼ −11.50% | ▼ −11.95% | $3.97 (−13.88%) |
Oct 7, 2026 19d ago | SC 13G | $4.62 $4.61 | ▼ −0.22% | ▲ +0.76% | $3.97 (−14.07%) |
Oct 7, 2026 19d ago | SC 13G/A | $4.62 $4.61 | ▲ +0.22% | ▼ −0.76% | $3.97 (+14.07%) |
Sep 29, 2026 27d ago | 8-K | $4.67 $4.61 | ▼ −1.28% | ▼ −3.23% | $3.97 (−14.99%) |
Sep 25, 2026 4w ago | 8-K | $4.68 $4.55 | ▼ −2.78% | ▼ −2.56% | $3.97 (−15.17%) |
Sep 17, 2026 5w ago | 8-K | $4.66 $4.82 | ▲ +3.43% | ▲ +2.83% | $3.97 (−14.81%) |
Sep 16, 2026 5w ago | Insider Cluster | $4.82 $4.70 | ▼ −2.49% | ▼ −5.05% | $3.97 (−17.63%) |
Aug 15, 2026 10w ago | Institutional Cluster | $4.29 $4.80 | ▲ +11.89% | ▲ +13.08% | $3.97 (−7.46%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers